Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Eastern Cooperative Oncology Group
University of California, Irvine
Children's Oncology Group
Thomas Jefferson University
Masonic Cancer Center, University of Minnesota
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center